celulas derivadas de placenta a termino
TRANSCRIPT
-
7/23/2019 Celulas Derivadas de Placenta a Termino
1/11
Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011276
Artculo de revisin
Rev Hematol Mex 2011;12(4):276-286
Utilidad teraputica potencial de las clulas madre de la membranaamniticaCarmen L Insausti,* Miguel Blanquer,* Mara J Majado,* Alfredo Insausti,** Jos M Moraleda*,***
RESUMEN
Desde los primeros estudios de clulas madre obtenidas de la membrana amnitica se ha avanzado mucho en el conocimiento de las
caractersticas de estas clulas, sus mtodos de obtencin y procesamiento, as como de su potencialidad. Numerosos ensayos preclnicos
sugieren que las clulas madre de la membrana amnitica podran ser tiles en la regeneracin de una serie de alteraciones tisulares.
estrecha colaboracin entre la investigacin bsica y los clnicos para que la terapia con clulas se haga realidad en la prctica diaria.
Palabras clave: membrana amnitica, clulas madre, clulas de la membrana amnitica, clulas epiteliales, clulas mesenquimales,terapia celular.
ABSTRACT
handling methods and potential of these cells. A lot of preclinical evidence suggests that human amniotic derived cells may be useful for
of amniotic derived cells are due to differentiation of the transplanted cells themselves or to paracrine actions on the surrounding host tissue
clinical reality, it is fundamental a close collaboration between basic scientists and clinicians.
Key words:Amnion, amniotic membrane, stem cell, amniotic epithelial stem cell, amniotic mesenchymal stem cell, Cell therapy.
* Servicio de Hematologa y Hemoterapia. Unidad de TerapiaCelular. Hospital Universitario Virgen de la Arrixaca.
** Servicio de Oftalmologa. Hospital Universitario La Paz, Madrid.*** Universidad de Murcia. Murcia, Madrid.
Correspondencia: Dra. Carmen L Insausti. Servicio de Hematologa
y Hemoterapia, Unidad de Terapia Celular. Hospital UniversitarioVirgen de la Arrixaca. Ctra. Madrid-Cartagena. El Palmar 30120,Murcia. Correo electrnico: [email protected]: octubre 2011. Aceptado: noviembre 2011.
Este artculo debe citarse como: Insausti CL, Blanquer M, MajadoMJ, Insausti A, Moraleda JM. Utilidad teraputica potencial delas clulas madre de la membrana amnitica. Rev Hematol Mex2011;12(4):276-286.
L
- 1,2
2 1-4
acelular,
-
-
7/23/2019 Celulas Derivadas de Placenta a Termino
2/11
277Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011
Utilidad teraputica potencial de las clulas madre de la membrana amnitica
fuera de sta se encuentra una capa dispersa de clulas
3,4
- human Amniotic Epithelial cells, - -
human Amniotic MesenchymalStem or Stromal cells -
- -
invitro
Tumor Necrosis Factor) Transforming factor) (Epidermal Growth Factor Hepatic
growth factor Keratinocytesgrowth factor -
Usos de las hAEC y hAMSC en modelos animales
- -
Brain derived netrophic factor y NT-3:eurotrophin-3) 28
-
-
7/23/2019 Celulas Derivadas de Placenta a Termino
3/11
Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011278
L Insausti C y col.
Cuadro 1.Trasplante de HAEC o HAMSC en modelos animales de enfermedades
Enfermedad Animal Evolucin Referencias
Enfermedad de Parkinson
Contusin del cordn medular
Obstruccin arterial cerebral media
Tejido heptico
Fibrosis heptica
Infarto cardiaco
Diabetes
Fibrosis pulmonar
Tejido cartilaginoso
Enfermedades del odo
Pared abdominal
Isquemia de extremidades
Rata
Ratn
Rata
Mono
Rata
Rata
Ratn
Conejo
Ratn
Rata
Ratn
Ratn
Ratn
Rata
Cobayo
Rata
Ratn
Supervivencia celular. Sntesis y secrecin de catecolaminas y factores
-
paminrgicas.
Efecto neuroprotector y neurognico.
Mejora clnica. Expresin de marcadores neurales
Integracin celular sin reaccin inmunitaria
Supervivencia celular. Expresin de marcadores neuronales. Disminucin
del rea infartada. Mejora clnica
Integracin en tejido heptico. Expresin de marcadores hepticos.
Integracin heptica. Expresin de receptores.
Supervivencia celular. Expresin de marcadores cardiacos. Mejora de
la funcin cardiaca.Correccin de hiperglucemia. Integracin celular en el hgado y el pncreas
Produccin de protenas surfactantes A, B, C y D.
Expresin de genes, receptores, colgeno tipo II y aggrecan
Localizacin en la regin supra-limbal, regin supra-espiral en la scala
vestibuliy en la regin subcentral del ligamento espiral en la scala timpani.
Supervivencia durante 3 semanas. Expresin de marcadores.
Integracin celular. Mejora de cicatrizacin. Reduccin de la incidencia
y tamao de hernias incisionales.
27,28,
29
30
31
32
33
5,35,37,39
36
40
41,42
44
45,46
18
47
48
49
- - 3,4-Dihydroxyphenylaceticacid: Homovanilic acid) en el striatum del
-
-31
32 -
33tras el tras-
-
7/23/2019 Celulas Derivadas de Placenta a Termino
4/11
279Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011
Utilidad teraputica potencial de las clulas madre de la membrana amnitica
34 fuente de clulas para la terapia celular en ictus, una
-
-
-
36 Low density lipoprotein receptor
- -
-
38 - -
present tripsina humana.
en
4), trasplan-
41
-
7/23/2019 Celulas Derivadas de Placenta a Termino
5/11
Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011280
L Insausti C y col.
-
2
-
42
43 -
- -
44 -
2
- - -
-
46
18
- - en la matriz pericelular.
-
7/23/2019 Celulas Derivadas de Placenta a Termino
6/11
281Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011
Utilidad teraputica potencial de las clulas madre de la membrana amnitica
-
in vitro - - invivo - lascala vestibuli espiral en lascala timpani,
48 - Amniotic multipotentcells -
-
- -
in vivo de 18,33,41 -
-
-
enfermedades.
- -
-
7/23/2019 Celulas Derivadas de Placenta a Termino
7/11
Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011282
L Insausti C y col.
-
-
61
-
-
1. -
6
-
-
-
- 6
- pacientes.
- 6 6
-
7/23/2019 Celulas Derivadas de Placenta a Termino
8/11
283Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011
Utilidad teraputica potencial de las clulas madre de la membrana amnitica
-
Cuadro 2.Publicaciones recientes acerca de la indicacin clnica de la membrana amnitica
Aos Ttulos Referencias
2000
2001
2003
2004
2005
2006
2007
2008
2009
2010
Reconstitution of damaged corneas by transplantation of autologous limbal epithelial cells
Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases.
Successful reconstruction of damaged ocular outer surface in humans using limbal and conjuctival stem cell
culture methods.
The Amniotic membrane in ophthalmology
Amniotic membrane use in ophthalmology
Amniotic membrane transplantation for ocular surface reconstruction.
Ultrastructural analysis of in vivo expanded corneal epithelium on amniotic membrane
Amniotic membrane transplantation for treatment of symblepharon in a patient with recessive dystrophic epi-
dermolysis bullosa.Amniotic Membrane transplantation in palliative treatment of bullous keratopathy
Clinical outcome of autologous cultivated limbal epithelium transplantation
Amniotic Membrane Transplantation
Use of amniotic membrane graft and corneal transplantation in a patient with bilateral keratomalacia induced
by uncontrolled phenylketonuria
Use of amniotic membrane transplantation in the treatment of venous leg ulcers.
Amnia for intractable skin ulcers with recessive dystrophic epidermolysis bullosa: report of three cases.
Amniotic membrane transplantation for the management of corneal epithelial defects: an in vivo confocal mi-
croscopic study.
Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials
Amniotic membrane transplantation in the treatment of persistent epithelial defect on the corneal graft.Use of amniotic membrane transplantation in isolated conjunctival Bowen disease: a case report
Dried irradiated human amniotic membrane as a biological dressing for facial burns--a 7-year case series
Amniotic membrane induces epithelialization in massive posttraumatic wounds.
62
68
69
55
56
64
65
63
59
70
57
60
71
72
66
75
6761
73
74
experiencias en pacientes.
CONCLUSIN
- -
-
7/23/2019 Celulas Derivadas de Placenta a Termino
9/11
Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011284
L Insausti C y col.
- Good Manufacturing Practice -
Agradecimientos
-
REFERENCIAS
1. Bourne G. The Foetal Membranes. A Review of the Anatomy
of Normal Amnion and Chorion and Some Aspects of Their
Function. Postgrad Med J 1962;38:193-201.
2. Benirschke K., Kaufman P. Anatomy and Pathology of the
placental membranes. In: Pathology of the Human Placenta.
4th
ed. New York: Springer, 2000;281-334.3. Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, et al. Pro-
perties of the amniotic membrane for potential use in tissue
engineering. European Cells and materials 2008; 15:88-99.
4. Dobreva MP, Pereira PM, Deprest J, Zwijsen A. On the ori-
gin of amniotic stem cells: of mice and men. Int J Dev Biol
2010;54:761-777.
5. Miki T, Lehmann T, Cai H, Stolz D, Strom S. Stem cell charac-
teristics of amniotic epithelial cells. Stem Cells 2005;23:1549-
1559.
6. Miki T, Strom SC. Amnion derived pluripotent-multipotent stem
cells. Stem Cell Rev 2006;2:133-142.
7. Ilancheran S, Michalska A, Peh G, Wallace EM, et al. Stem
cell derived from human fetal membranes display multilineage
differentiation potential. Biol Reprod 2007;77(3):577-588.
8. Insausti CL, Blanquer M, Bleda P, Iniesta P, et al. The amnio-
tic membrane as a source of stem cells. Histol Histopathol
2010;25:91-98.
9. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human am-
niotic epithelial cells possess hepatocyte-like characteristics
and functions. Cell Struct Funct 2004;29:73-83.
10. Niknejad H, Peirovi H, Ahmadiani A, Ghanavi J, Jorjani M. Di-
in vitro from human amniotic epithelial cells. European Cells
and Materials 2010;19:22-29.
11. Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH.
Comparative Characterization of Cultured Human Term Am-
nion Epithelial and Mesenchymal Stromal Cells for Application
in Cell Therapy. Cell Transplantation 2008;17:955-968.
12. Parolini O, Soncini M. Human Placenta: a source of progenitor/
stem cells? J Reproduktionsmed Endokrinol 2006;3:117-126.
13. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, et al.
Placental mesenchymal stem cells as potential autologous
graft for pre and perinatal neuroregeneration. Am J Obstet
Gynecol 2006;194:664-673.
14. Parolini O, Alviano F, Bergwerf I, Boraschi D, et al. Toward cell
therapy using placenta-derived cells: Disease mechanisms,
cell biology, preclinical studies, and regulatory aspects at the
round table. Stem cells and development 2010;19:143-154.
15. Alviano F, Fossati V, Marchionni C, Arpinati M, et al. Term
amniotic membrane is a high throughput source for multipo-
tent mesenchymal stem cells with the ability to differentiate
into endothelial cells in vitro. BMC developmental. Biology
2007; 7:1-14.
16. Soncini M, Vertua E, Gibelli L, Zorzi F, et al. Isolation andcharacterization of mesenchymal cells from human fetal mem-
branes. J Tissue Eng Regen Med 2007; 1:296-305.
17. Kim J, Mi Kang H, Kim H, Ran Kim M, et al. Ex vivocharac-
teristics of human amniotic membrane- derived stem cells.
Cloning and stem cells 2007;9:581-594.
18. Wei JP, Nawata M, Wakitani S, Kametani K, et al. Human
amniotic mesenchymal cells differentiate into chondrocytes.
Cloning and Stem Cells 2009;11:19-25.
19. Parolini O, Alviano F, Bagnara G, Bilic G, et al. Concise Re-
view: Isolation and characterization of cells from human term
placenta: outcome of the First International Workshop on
Placenta Derived Stem Cells. Stem Cells 2008;26:300-311.
20. Whittle WL, Gibb W, Challis JRG. Characterization of human
amnion epithelial and mesenchymal cells: the cellular expres-
sion, activity and glucocorticoid regulation of prostaglandinoutput. Placenta 2000;21:394-401.
21. Li H, Niederkorn J, Neelam S, Mayhew E, et al. Immunosu-
ppressive factors secreted by human amniotic epithelial cells.
Invest Ophthalmol Vis Sci 2005; 46:900-907.
22. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, et al.
Growth factor mRNA and protein in preserved human amniotic
membrane. Curr Eye Res 2000;20:173-177.
23.
amniotic membrane. Cornea 2000;19:348-352.
24. Solomon A, Rosenblatt M, Monroy D, Ji Z, et al. Suppression
of interleukin 1 (alpha) and interleukin 1 (beta) in human limbal
epithelial cells cultured on the amniotic membrane stromal
matrix. Br J Ophthalmol 2001;85:444-449.
25. Houlihan JM, Biro PA, Harper HM. The human amnion is a
site of MHC class Ib expression: evidence for the expression
of HLA-E y HLA-G. J Immunol 1995;154:5665-5674.
26. Magatti M, de Munari S, Vertua E, Nassuato C, et al. Amniotic
mesenchymal tissue cell inhibit dendritic cell differentiation of
peripheral blood and amnion resident monocytes. Cell Trans-
plant 2009;18:899-914.
27. Kakishita K, Elwan MA, Nakao N, Itakura T, Sakurawaga N.
Human Amniotic epithelial cells produce dopamine and survive
after implantation into the striatum of a rat model of Parkinsons
-
7/23/2019 Celulas Derivadas de Placenta a Termino
10/11
285Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011
Utilidad teraputica potencial de las clulas madre de la membrana amnitica
disease: a potential source of donor for transplantation therapy.
Exp Neurol 2000;165:27-34.
28. Kakishita K, Nakao N, Sakurawaga N, Itakura T. Implantation
of human amniotic epithelial cells prevents the degeneration
of nigral dopamine neurons in rats with 6-hydroxydopamine
lesions. Brain Res 2003;980:48-56.
29. Kong XY, Cai Z, Pan L, Zhang L, et al. Transplantation of hu-
man amniotic cells exerts neuroprotection in MPTP-induced
Parkinson disease mice. Brain Res 2008; 1205:108-115.
30. Yang X, Xue S, Dong W, Kong Y. Therapeutic effect of hu-
man amniotic epithelial cell transplantation into the lateral
ventricle of hemiparkinsonian rats. Chinese Medical Journal
2009;122:2449-2454.
31. Sankar V, Muthusamy R. Role of human amniotic epithelial
cell transplantation in spinal cord injury repair research. Neu-
roscience 2003;118:1-17.
32. Wu ZY, Hui GZ, Lu Y, Wu X, Guo LH. Transplantation of human
amniotic epithelial cells improves hindlimb function in rats with
spinal cord injury. Chin Med J (Engl) 2006;119:2101-2107.
33. Liu Y, Wu J, Huang Q, Hou J, et al. Human Amniotic epithelialcells ameliorate behavioral dysfunction and reduce infarct
size in the rat middle cerebral artery occlusion model. Shock
2008;29:603-611.
34. Yu SJ, Soncini M, Kaneko Y, Hess DC, et al. Amnion a po-
tent graft source for cell therapy in stroke: Cell Transplant
2009;18:111-118.
35. Sakuragawa N, Enosawa S, Ishii T, Thangavel R, et al. Hu-
man amniotic epithelial cells are promising transgene carriers
for allogeneic cell transplantation into liver. J Hum Genet
2000;45:171-176.
36. Takahashi S, Ohsugi K, Yamamoto T, Shiomi M, Sakuragawa
N. A novel approach to ex vivo gene therapy for familiar
hypercholesterolemia using human amniotic epithelial cells
as transgene carrier. Tohoku J Exp Med 2001;193:279-292.
37. Takahashi N, Enosawa S, Mitani T, Lu H, et al. Transplantationof amniotic epithelial cells into fetal rat liver by in utero mani-
pulation. Cell Transplant 2002; 11:443-449.
38. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human am-
niotic epithelial cells possess hepatocyte-like characteristics
and functions. Cell Struct Funct 2004;29:73-83.
39. Miki T, Marongiu F, Ellis EC, Dorko K, et al. Production of
hepatocyte-like cells from human amnion. Methods Mol Biol
2009;481:1-14.
40. Manuelpillai I, Tchongue J, Lourensz D, Vaghjiani V, et al.
Transplantation of human amniotic epithelial cells reduce
4-treated mice. Cell
Transplantation 2010;19:1157-1168.
41. Zhao P, Ise H, Hongo M, Ota M, et al. Human amniotic me-
senchymal cells have some characteristics of cardiomyocytes.
Transplantation 2005;79:528-535.
42. Ventura C, Cantoni S, Bianchi F, Lionetti V, et al. Hyaluronan
mixed esters of butyric and retinoic acid drives cardiac and
endothelial fate in term placenta human mesenchymal stem
cells and enhance cardiac repair in infracted rat hearts. J Biol
Chem 2007;282:14243-14252.
43. Cargnoni A, Di Marcello M, Campagnol M, Nassuato C, et
al. Amniotic membrane patching promotes ischemic rat heart
repair. Cell Transplant 2009;18:1147-1159.
44. Wei JP, Zhang TS, Kawa S, Aizawa T, et al. Human amnion-iso-
lated cells normalize blood glucose in streptozotocin-induced
diabetic mice. Cell Transplant 2003;12:545-552.
45. Cargnoni A, Gibelli L, Tosini A, Signoroni PB, et al. Trans-
plantation of allogenic and xenogenic placenta derived cells
2009;18:405-422
46. Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, et al. Human
and augment repair. Am J Respi Crit Care Med 2010;182:643-
651.
47. Yuge I, Takumi Y, Koyabu K, Hashimoto S, et al. Transplanted
human amniotic epithelial express connexin 26 y Na-K-ATPasa
in the inner ear. Transplantation 2004;77:1452-1454.
48. Xing L, Franz MG, Marcelo CL, Smith CA, et al. Amnion-derived
multipotent progenitor cells increase gain of incisional breaking
strength and decrease incidence and severity of acute wound
failure. J Burns and Wounds 2007;7:39-52.
49. -
tal derived adherent stromal cell (PLX-PAD) in the treatment ofcritical limb ischemia. Cytotherapy 2009;11:427-434.
50. Davis JW. Skin transplantation with a review of 550 cases at
the John Hopkins Hospital. Johns Hopkins Med J 1910;15:307-
396.
51. Trefold JD, Trelford-Sauer M. The amnion in surgery, past and
present. Am J Obstet Gynecol 1979;134:833-845.
52. Ganatra MA. Amniotic membrane in surgery. J Pak Med Assoc
2003;53:29-32.
53. De Rotth A. Plastic repair of conjunctival defects with fetal
membranes. Arch Ophthalmol 1940;23(5):22-525.
54. Sorby A, Symons HM. Amniotic membrane grafts in caustic
burns of eye. Br J Ophthalmol 1946;30:337-345.
55. Dua HS, Gomes JA, King AJ, Maharajan S. The Amniotic
membrane in ophthalmology. Survey of Ophthalmology
2004;49:51-77.56. Gomes JA, Roman A, Santos MS, Dua HS. Amniotic membra-
ne use in ophthalmology. Curr Opin Ophthalmol 2005;16:233-
240.
57.
Amniotic membrane transplantation. Iranian J Ophthalmolol
Res 2007;2:58-73.
58. Kim JC y Tseng SC. Transplantation of preserved human
amniotic membrane for surface reconstruction in severely
damaged rabbit corneas. Cornea 1995;14: 473-484.
59. Zemba M, Andrei S, Cucu B, Bratulescu M, et al. Amniotic
Membrane transplantation in palliative treatment of bullous
keratopathy. Oftalmologia 2006;50:51-53.
60. Habot-Wilner Z, Spierer A, Barequet IS, Greenbaum A. Use
of amniotic membrane graft and corneal transplantation in a
patient with bilateral keratomalacia induced by uncontrolled
phenylketonuria. Cornea 2007;26:629-631.
61. Motolese J, Mazzera L, Frezzotti P, Motolese PA, Motolese
E. Use of amniotic membrane transplantation in isolated
conjunctival Bowen disease: a case report. Eur J Ophthalmol
2010; 20:604-607.
62. Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas
by transplantation of autologous limbal epithelial cells. N Engl
J Med 2000;343:86-93.
-
7/23/2019 Celulas Derivadas de Placenta a Termino
11/11
Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011286
L Insausti C y col.
63. Altan-Yaycioglu R, Akova YA, Oto S. Amniotic membrane
transplantation for treatment of symblepharon in a patient
with recessive dystrophic epidermolysis bullosa. Cornea
2006; 25:971-973.
64. Fernandes M, Sridhar MS, Sangwan VS, Rao GN. Amniotic
membrane transplantation for ocular surface reconstruction.
Cornea 2005;24:643-653.
65. Ha HS, Song KY, Kim JC. Ultrastructural analysis of in vivo
expanded corneal epithelium on amniotic membrane. J Korean
Med Sci 2006;21:544-549.
66. Nubile M, Dua HS, Evb-M Lanzini T, Carpineto P, et al. Amniotic
membrane transplantation for the management of corneal
epithelial defects: an in vivo confocal microscopic study. Br J
Ophthalmol 2008;92:54-60.
67. Dekaris I, Mravicic I, Barisic A, Draca N, Pauk M. Amniotic
membrane transplantation in the treatment of persistent
epithelial defect on the corneal graft. Cell Antropol 2010;34
Suppl 2:15-19.
68. Muraine M, Descargues G, Franck O, Villeroy F, et al. Amniotic
membrane graft in ocular surface disease. Prospective studywith 31 cases. J Fr Ophtalmol 2001;24:798-812.
69. Sangwan VS, Vemuganti GK, Singh S, Balasubramanian D.
Successful reconstruction of damaged ocular outer surface
in humans using limbal and conjunctival stem cell culture
methods. Biosci Rep 2003;23:169-174.
70. Sangwan VS, Matalia HP, Vemuganti GK, Fatima A, et al.
Clinical outcome of autologous cultivated limbal epithelium
transplantation. Indian J Ophthalmol 2006; 54:29-34.
71. Mermet I, Pottier N, Sainthillier JM, Malugani C, et al. Use of
amniotic membrane transplantation in the treatment of venous
leg ulcers. Wound Repair Regen 2007;15: 459-464.
72. Hasegawa T, Mizoguchi M, Haruna K, Mizuno Y, et al. Amnia for
intractable skin ulcers with recessive dystrophic epidermolysis
bullosa: report of three cases. J Dermatol 2007;34:328-332.
73. Bujang-Safawi E, Halim AS, Khoo TL, Dorai AA. Dried irradia-
ted human amniotic membrane as a biological dressing for
facial burns--a 7-year case series. Burns 2010;36: 876-882.
74. Insausti CL, Alcarz A, Garca-Vizcano EM, Mrowiec A, et
al. Amniotic membrane induces epithelialization in massive
posttraumatic wounds. Wound Rep Reg 2010;18:368-377.
75. Brooke G, Rosstti T, Pelekanos R, Ilic N, et al. Manufacturingof human placenta-derived mesenchymal stem cells for clinical
trials. British J Haematol 2009;144:571-579.